Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification

Stopped Change of company's priority; learning from a separate CT-101-CLS-001 (NCT04857515) is deemed sufficient

Conditions

• Nicotine Addiction
• Drug Addiction
• Drug Dependence
• Substance Use Disorder
• Tobacco Dependence

Interventions

• DEVICE: Treatment A with device Clickotine® (Active intervention)
• DEVICE: Treatment B with smoking education (control)

Sponsor

Click Therapeutics, Inc.